Innovation

Our Innovation

RUBYnanomed innovated in developing an automated, easy-to-use and fully streamlined workflow for liquid biopsy

Innovation
Processing and Staining
Innovation
Imaging and Analysis

RUBYchip™ is complemented with automated sample processing, staining, image acquisition and analysis, ensuring reliability. Low inter-laboratory and fast implementation towards non-invasive and continuous monitoring of patients.

Our Projects

Ongoing

BRIGHT EU

EIC Accelerator by European Innovation Council
Ongoing

BIOCELLPHE

EU Horizon 2020
Finished

BRIGHT PT

AVISO 18 Norte 2020
Finished

PERSIST

EU Horizon 2020
Finished

CTC-OncoDynamics

Caixa Impulse Consolidate by LA CAIXA Foundation

Partnerships

Publications

Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study
Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients
HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device
The Significance of Circulating Tumour Cells in the Clinic
Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications
Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases